Fortress Biotech, Inc. (FBIO)
3.18
+0.12
(+3.92%)
USD |
NASDAQ |
Mar 04, 14:12
Fortress Biotech Cash from Investing (Quarterly) : 2.87M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | -288.10M |
| Oramed Pharmaceuticals, Inc. | 38.82M |
| Avenue Therapeutics, Inc. | 0.00 |
| Lyell Immunopharma, Inc. | 3.349M |
| Climb Bio, Inc. | 15.26M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.11M |
| Cash from Financing (Quarterly) | 15.07M |
| Free Cash Flow | -30.14M |
| Free Cash Flow Per Share (Quarterly) | -0.1846 |
| Free Cash Flow to Equity (Quarterly) | -5.184M |
| Free Cash Flow to Firm (Quarterly) | -3.376M |
| Free Cash Flow Yield | -32.32% |